SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences informs about clarification on price movements

18 May 2021 Evaluate

With reference to the communication dated May 14, 2021, seeking clarification for movement in price, Gufic Biosciences has clarified that there is no pending information or announcement (including impending announcement) from the Company which in its opinion may have a bearing on the price / volume behaviour in the scrip. The movement in the shares price of the Company is purely due to market conditions and absolutely market driven and the Management of the Company is no way connected with any such price increase/volume increase.

The above information is a part of company’s filings submitted to BSE.

Gufic Biosciences Share Price

301.30 -1.35 (-0.45%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×